Ardelyx, Inc. (ARDX): Price and Financial Metrics
ARDX Price/Volume Stats
| Current price | $6.44 | 52-week high | $10.13 |
| Prev. close | $6.44 | 52-week low | $3.16 |
| Day low | $6.44 | Volume | 7,509 |
| Day high | $6.44 | Avg. volume | 6,057,852 |
| 50-day MA | $8.18 | Dividend yield | N/A |
| 200-day MA | $5.75 | Market Cap | 1.50B |
ARDX Stock Price Chart Interactive Chart >
Ardelyx, Inc. (ARDX) Company Bio
Ardelyx is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative, minimally-systemic, small molecule therapeutics that work exclusively in the gastrointestinal tract to treat cardio-renal, gastrointestinal and metabolic diseases. The company was founded in 2007 and is based in Fremont, California.
Latest ARDX News From Around the Web
Below are the latest news stories about ARDELYX INC that investors may wish to consider to help them evaluate ARDX as an investment opportunity.
Ardelyx, Inc. Reports Employment Inducement GrantsWALTHAM, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that on December 18, 2023, the compensation committee of the company’s board of directors granted sixteen new non-executive employees options to purchase an aggregate of 257,119 shares of the company’s common stock, and granted eighte |
There's Reason For Concern Over Ardelyx, Inc.'s (NASDAQ:ARDX) Massive 36% Price JumpDespite an already strong run, Ardelyx, Inc. ( NASDAQ:ARDX ) shares have been powering on, with a gain of 36% in the... |
3 Short-Squeeze Stocks Ready for a Year-End RallyThese are a few companies that have seen considerable gains this year that still have a large percentage of short interest. |
3 Stocks at the Forefront of Personalized Medicine TrendIn the rapidly evolving healthcare sector, the idea of personalized medicine stocks stands out, revolutionizing patient care by tailoring treatments with their individual genetic profiles. These stocks highlight the trend of focusing on genetic and molecular characteristics, promising more effective healthcare solutions. This trend transcends medical innovation, marking its territory as a burgeoning economic powerhouse. Grand View Research forecasts the global personalized medicine market to rea |
7 Penny Stocks You’ll Regret Not Buying Soon: November 2023Unlock robust upside potential by wagering on these top penny stocks to buy in a volatile market at this time. |
ARDX Price Returns
| 1-mo | -17.44% |
| 3-mo | -22.22% |
| 6-mo | 80.90% |
| 1-year | 34.73% |
| 3-year | -20.20% |
| 5-year | 90.53% |
| YTD | 3.87% |
| 2023 | 117.54% |
| 2022 | 159.09% |
| 2021 | -83.00% |
| 2020 | -13.79% |
| 2019 | 319.27% |
Continue Researching ARDX
Here are a few links from around the web to help you further your research on Ardelyx Inc's stock as an investment opportunity:Ardelyx Inc (ARDX) Stock Price | Nasdaq
Ardelyx Inc (ARDX) Stock Quote, History and News - Yahoo Finance
Ardelyx Inc (ARDX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...